CompletedPhase 3NCT02357576
Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
Studying Parenteral nutrition-associated cholestasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Michigan
- Principal Investigator
- Meghan A Arnold, MDUniversity of Michigan
- Intervention
- Intralipid 20% I.V. Fat Emulsion(drug)
- Enrollment
- 22 target
- Eligibility
- 1 years · All sexes
- Timeline
- 2016 – 2019
Study locations (5)
- University of Colorado/Children's Hospital Colorado, Aurora, Colorado, United States
- University of Florida, Gainesville, Florida, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Primary Children's Hospital, Salt Lake City, Utah, United States
- Seattle Children's Hospital, Seattle, Washington, United States
Collaborators
Seattle Children's Hospital · University of Florida · Primary Children's Hospital · University of Colorado, Denver
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02357576 on ClinicalTrials.govOther trials for Parenteral nutrition-associated cholestasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06274788Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentFresenius Kabi
- RECRUITINGPHASE4NCT06049680Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult PatientsFresenius Kabi
See all trials for Parenteral nutrition-associated cholestasis →